Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Chinese Patent Office
Cipla
Healthtrust
Mallinckrodt
US Army

Generated: March 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for BIIB021

« Back to Dashboard

US Patents for BIIB021

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
BIIB021 ➤ Sign Up Methods for treating cancer using TOR kinase inhibitor combination therapy comprising administering substituted pyrazino[2,3-b]pyrazines Signal Pharmaceuticals, LLC (San Diego, CA) ➤ Sign Up
BIIB021 ➤ Sign Up 2-aminopurine analogs having HSP90-inhibiting activity Conforma Therapeutics Corporation (San Diego, CA) ➤ Sign Up
BIIB021 ➤ Sign Up Methods of using MEK inhibitors Exelixis, Inc. (South San Francisco, CA) ➤ Sign Up
BIIB021 ➤ Sign Up Combination therapies comprising quinoxaline inhibitors of P13K-alpha for use in the treatment of cancer Exelixis, Inc. (South San Francisco, CA) ➤ Sign Up
BIIB021 ➤ Sign Up Methods of treating cancer using pyridopyrimidinone inhibitors of PI3K alpha Exelixis, Inc. (South San Francisco, CA) ➤ Sign Up
BIIB021 ➤ Sign Up GRP94 inhibitors University of Kansas (Lawrence, KS) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for BIIB021

Drugname Country Document Number Estimated Expiration Related US Patent
BIIB021 European Patent Office 3131552 2034-04-16 ➤ Sign Up
BIIB021 Japan 2017514806 2034-04-16 ➤ Sign Up
BIIB021 New Zealand 629860 2034-04-16 ➤ Sign Up
BIIB021 World Intellectual Property Organization (WIPO) 2015160868 2034-04-16 ➤ Sign Up
BIIB021 Australia 2002343604 2021-10-30 ➤ Sign Up
BIIB021 Australia 2004274507 2021-10-30 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Colorcon
Daiichi Sankyo
Queensland Health
AstraZeneca
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.